NAYA (NAYA Biosciences) Cash per Share : $1.45 (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is NAYA Biosciences Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). NAYA Biosciences's Cash per Share for the quarter that ended in Sep. 2024 was $1.45.

NAYA Biosciences Cash per Share Historical Data

The historical data trend for NAYA Biosciences's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NAYA Biosciences Cash per Share Chart

NAYA Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash per Share

Get a 7-Day Free Trial

61.95

252.45

113.70

1.77

1.12

NAYA Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash per Share	Get a 7-Day Free Trial															5.13	1.12	2.18	2.93	1.45

NAYA Biosciences Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

NAYA Biosciences's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	0.232	/	0.21
	=	1.12

NAYA Biosciences's Cash per Share for the quarter that ended in Sep. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	0.472	/	0.33
	=	1.45

NAYA Biosciences (NAS:NAYA) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

NAYA Biosciences Cash per Share Related Terms

Thank you for viewing the detailed overview of NAYA Biosciences's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

NAYA Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NAYA Biosciences Inc (NAS:NAYA) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

5582 Broadcast Court, Sarasota, FL, USA, 34240

Website

https://www.nayabiosciences.com

NAYA Biosciences operates a healthcare services fertility business as well as expand its focus to the development of first-in-class clinical-stage assets in oncology and autoimmune diseases.

Executives

Trent D Davis	director	811 SW NAITO PARKWAY, SUITE 200, PORTLAND OR 97204
Matthew K Szot	director	802 NORTH DOUTY STREET, HANFORD CA 93230
Steve Shum	director	9025 SW HILLMAN COURT, SUITE 3126, WILSONVILLE OR 97070
Andrea Goren	officer: Chief Financial Officer	110 EAST 59TH STREET, SUITE 1901, NEW YORK NY 10022
Barbara Ryan	director	22 CAVRAY ROAD, NORWALK CT 06855
Michael Jos. Campbell	director	61 SOUTH HILLS DRIVE, BEDFORD NH 03110
Rebecca Messina	director	5582 BROADCAST COURT, SARASOTA FL 34240
Jeffrey Segal	director	INVO BIOSCIENCE, INC., 5582 BROADCAST COURT, SARASOTA FL 34240
Awm Investment Company, Inc.	10 percent owner	527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Kevin Doody	director, officer: Medical Director	1109 SOMERSET BLVD, COLLEYVILLE TX 76034
Debra Robbins Hoopes	officer: Acting CFO and PFO	1 MORTON DR., SUITE 200, CHARLOTTESVILLE VA 22903
Claude Ranoux	10 percent owner	8 CHESTNUT STREET, WINCHESTER MA 01890
Kathleen T Karloff	director, officer: CEO/Chairman	109 BEACON STREET UNIT 5, BOSTON MA 02116
Bowdring Robert Joseph Jr	officer: Chief Financial Officer	92 GOULD STREET, WAKEFIELD MA 01880